Singapore, March 15 -- PsiQuantum has signed a collaborative research agreement with the National Cancer Center Japan, a leading cancer treatment and research facility, to advance applications in oncology and healthcare for utility-scale quantum computers.

This new agreement underscores the enormous potential for utility-scale quantum computing across the healthcare value chain, specifically in research and development, resource allocation, and patient outcomes in cancer treatment.

Under the newly formed collaboration, PsiQuantum will work alongside the National Cancer Center Japan to advance fault-tolerant quantum algorithm development and collaborate with the National Cancer Center Japan and other leading pharmaceutical companies in J...